Skip to main contentSkip to navigation
Sirius Investors

MKKGY Stock: Merck KGaA Stock Price, Analysis & Insights

Get live MKKGY stock price $31.35, comprehensive Merck KGaA stock analysis, charts, news, and expert forecast. Real-time MKKGY stock data and investment insights.

31.35
2.25%Today
MKKGYMerck KGaA • Other OTC • Healthcare
Market Cap
68.15B
Volume
14.20K
52W High
32.48
52W Low
23.73

Loading chart data...

Merck KGaA (MKKGY) Overview

Merck KGaA (MKKGY) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, MKKGY trades at $31.35 with a market capitalization of 68.15B . Over the past 52 weeks, MKKGY has traded between $23.73 and $32.48 , with the current price positioned at approximately 87% of this range . The stoc...

Key Takeaways

  • Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
  • Market cap: 68.15B
  • Current price: $31.35
  • 52-week range: $23.73 - $32.48
  • P/E ratio: 23.22

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Merck KGaA is a leading German science and technology enterprise. Its business operations are strategically organized into three core divisions: Life Science, Healthcare, and Electronics. The Life Science segment provides an extensive portfolio of to...

Company Information

CEO
Belen Garijo Lopez
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
59020

Contact Information

Address
Frankfurter Strasse 250
Country
DE

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - Specialty & Generic

Investment Highlights

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 23.2)

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Merck KGaA shareholders
  • Market volatility can significantly impact stock price, especially for mid-cap stocks
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Merck KGaA
  • Investors should consider how Merck KGaA fits within their overall portfolio allocation

Market Cap

68.15B

P/E Ratio (TTM)

23.22

Beta

0.81

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.